• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Open Lower; Dow Tumbles 400 Points

    9/23/22 10:11:06 AM ET
    $AORT
    $ATXI
    $CO
    $EVTL
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AORT alert in real time by email

    U.S. stocks traded lower this morning, with the Dow Jones dropping around 400 points on Friday.

    Following the market opening Friday, the Dow traded down 1.34% to 29,673.72 while the NASDAQ fell 1.96% to 10,849.83. The S&P 500 also fell, dropping, 1.75% to 3,692.24.

    Also check this: Ethereum Rises Above This Major Level, Here Are Other Crypto Movers That Should Be On Your Radar Today


    Leading and Lagging Sectors


    Health care shares fell by just 0.7% on Friday. Meanwhile, top gainers in the sector included Cassava Sciences, Inc. (NASDAQ:SAVA), up 35% and Talkspace, Inc. (NASDAQ:TALK) up 17%.


    In trading on Friday, energy shares dipped by 6.5%.


    Top Headline


    The S&P Global services PMI climbed to 49.2 in September from 43.7 in the prior month, while manufacturing PMI rose to 51.8 in September from 51.5 in August.


    Equities Trading UP

     

    • Snow Lake Resources Ltd. (NASDAQ:LITM) shares shot up 25% to $2.88 following news the company will collaborate with an LG unit to form a North American supply chain for lithium.
    • Shares of Vertical Aerospace Ltd. (NYSE:EVTL) got a boost, shooting 15% to $7.19.
    • Global Cord Blood Corporation (NYSE:CO) shares were also up, gaining 17% to $2.6032.

     

    Equities Trading DOWN

    • Avenue Therapeutics, Inc. (NASDAQ:ATXI) shares tumbled 28% to $4.7601 after the company received the official meeting minutes from the FDA regarding a meeting conducted for IV Tramadol in combination with other opioid analgesics to manage moderate-to-moderately severe pain. Concurrently, Avenue Therapeutics announced that it would effect a 1-for-15 reverse stock split.
    • Shares of Silver Crest Acquisition Corporation (NASDAQ:SLCR) were down 22% to $7.18
    • Artivion, Inc. (NYSE:AORT) was down, falling 19% to $15.05 after the company announced that it has stopped the PROACT Xa clinical trial.


    Also check out: Why Fear Level Among US Investors Is Increasing


    Commodities

    In commodity news, oil traded down 5.5% to $78.90, while gold traded down 1.7% at $ 1,652.50.


    Silver traded down 3.6% to $18.92 on Friday while copper fell 3.9% to $3.3375.


    Euro zone


    European shares were lower today. The eurozone’s STOXX 600 fell 2.2%, London’s FTSE 100 fell 2.3% while Spain’s IBEX 35 Index fell 2.5%. The German DAX dropped 1.9%, French CAC 40 fell 2.4% and Italy’s FTSE MIB Index fell 3.1%.


    The S&P Global Flash Eurozone services PMI declined to 48.9 in September from 49.8 in August, while manufacturing PMI slipped to 48.5 from 49.6. The S&P Global Flash Eurozone Composite PMI dropped to 48.2 in September from August’s reading of 48.9.


    The S&P Global/CIPS UK manufacturing PMI climbed to 48.5 in September from 47.3 a month ago, while GfK consumer confidence indicator declined to -49 in September from -44 in the previous month. French composite PMI increased to 51.2 in September versus a 17-month low level of 50.4 in August, while German composite PMI declined to 45.9 from 46.9 in August. Spanish quarterly economic growth accelerated to 1.5% in the second quarter versus a preliminary reading of 1.1%.

     

    Economics

     

    • The S&P Global services PMI climbed to 49.2 in September from 43.7 in the prior month, while manufacturing PMI rose to 51.8 in September from 51.5 in August.
    • The Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.
    • US Federal Reserve Chair Jerome Powell is set to speak at 2:00 p.m. ET.
    • Federal Reserve Vice Chair Lael Brainard Lael Brainard and Federal Reserve Governor Michelle Bowman will speak at 2:05 p.m. ET.


    Check out this:
    US Stocks Settle Lower For Third Consecutive Session Amid Low Volatility


    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 97,795,720 cases with around 1,080,830 deaths. India confirmed a total of at least 44,558,420 cases and 528,440 deaths, while France reported over 35,050,130 COVID-19 cases with 154,850 deaths. In total, there were at least 619,319,370 cases of COVID-19 worldwide with more than 6,537,030 deaths.

    Get the next $AORT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AORT
    $ATXI
    $CO
    $EVTL

    CompanyDatePrice TargetRatingAnalyst
    Artivion Inc.
    $AORT
    4/10/2026$42.00Neutral → Buy
    Ladenburg Thalmann
    Vertical Aerospace Ltd.
    $EVTL
    2/23/2026Mkt Perform → Underperform
    Raymond James
    Vertical Aerospace Ltd.
    $EVTL
    1/7/2026Outperform
    William Blair
    Talkspace Inc.
    $TALK
    12/9/2025$3.50Equal Weight
    Barclays
    Talkspace Inc.
    $TALK
    10/31/2025$5.00Hold → Buy
    Needham
    Vertical Aerospace Ltd.
    $EVTL
    8/22/2025$8.00Overweight
    Cantor Fitzgerald
    Artivion Inc.
    $AORT
    8/13/2025$38.79Buy → Neutral
    Ladenburg Thalmann
    Vertical Aerospace Ltd.
    $EVTL
    7/17/2025$9.00Buy
    Needham
    More analyst ratings

    $AORT
    $ATXI
    $CO
    $EVTL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Simpson Stuart

    4 - Vertical Aerospace Ltd. (0001867102) (Issuer)

    4/22/26 4:01:40 PM ET
    $EVTL
    Aerospace
    Industrials

    SEC Form 4 filed by Slattery Domhnal

    4 - Vertical Aerospace Ltd. (0001867102) (Issuer)

    4/22/26 4:02:14 PM ET
    $EVTL
    Aerospace
    Industrials

    SEC Form 4 filed by Saba Capital Management, L.P.

    4 - Vertical Aerospace Ltd. (0001867102) (Issuer)

    4/16/26 9:50:52 AM ET
    $EVTL
    Aerospace
    Industrials

    $AORT
    $ATXI
    $CO
    $EVTL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Anderson Robert Eugene Jr bought $24,940 worth of shares (8,600 units at $2.90) (SEC Form 4)

    4 - CASSAVA SCIENCES INC (0001069530) (Issuer)

    11/25/25 4:06:25 PM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President & CEO Barry Richard bought $414,000 worth of shares (150,000 units at $2.76) (SEC Form 4)

    4 - CASSAVA SCIENCES INC (0001069530) (Issuer)

    11/24/25 4:02:17 PM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President & CEO Barry Richard bought $201,809 worth of shares (73,385 units at $2.75) (SEC Form 4)

    4 - CASSAVA SCIENCES INC (0001069530) (Issuer)

    11/20/25 5:39:26 PM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AORT
    $ATXI
    $CO
    $EVTL
    SEC Filings

    View All

    SEC Form DEFM14A filed by Talkspace Inc.

    DEFM14A - Talkspace, Inc. (0001803901) (Filer)

    4/20/26 4:05:37 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    SEC Form 424B5 filed by Vertical Aerospace Ltd.

    424B5 - Vertical Aerospace Ltd. (0001867102) (Filer)

    4/20/26 8:54:33 AM ET
    $EVTL
    Aerospace
    Industrials

    SEC Form 424B5 filed by Vertical Aerospace Ltd.

    424B5 - Vertical Aerospace Ltd. (0001867102) (Filer)

    4/20/26 8:51:53 AM ET
    $EVTL
    Aerospace
    Industrials

    $AORT
    $ATXI
    $CO
    $EVTL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results

    ATLANTA, April 23, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE:AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2026 financial results will be released on Thursday, May 7, 2026, after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question-and-answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion. To listen to the live teleconference, please dial 201-689-8261 a few minutes p

    4/23/26 4:15:00 PM ET
    $AORT
    Medical/Dental Instruments
    Health Care

    Vertical Aerospace Announces Execution and Closing of Comprehensive Financing Package of up to $850 Million

    Vertical Aerospace ("Vertical" or "Company") (NYSE:EVTL), a global aerospace and technology company that is pioneering electric aviation, announced today that it has executed and closed the remaining components of its previously announced comprehensive financing package totaling up to $850 million. The comprehensive financing package, originally announced on March 30, 2026 as an $800 million agreement in principle alongside a completed $50 million equity capital raise, positions Vertical to deliver on the technical and operational milestones on its strategic road map, while also maintaining flexibility to access other capital sources outside of the package in the future. With the closin

    4/20/26 8:06:00 AM ET
    $EVTL
    Aerospace
    Industrials

    Vertical Aerospace Achieves World First Two-Way Piloted Transition Flight

    First eVTOL to complete two-way piloted transition – switching from helicopter mode to airplane mode and back again - under civil aviation Design Organisation Approval regulatory oversight Advances Valo's path to certification, targeted for 2028, with entry into service expected shortly thereafter on routes such as Canary Wharf to Heathrow and JFK to Manhattan Reinforces UK leadership in next-generation aerospace, supporting high-skill jobs and export growth Vertical Aerospace ("Vertical" or "the Company") (NYSE:EVTL), a global aerospace and technology company pioneering electric aviation, has successfully completed a historic two-way piloted transition flight. This press release

    4/16/26 6:41:00 AM ET
    $EVTL
    Aerospace
    Industrials

    $AORT
    $ATXI
    $CO
    $EVTL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Artivion upgraded by Ladenburg Thalmann with a new price target

    Ladenburg Thalmann upgraded Artivion from Neutral to Buy and set a new price target of $42.00

    4/10/26 8:27:02 AM ET
    $AORT
    Medical/Dental Instruments
    Health Care

    Vertical Aerospace Group downgraded by Raymond James

    Raymond James downgraded Vertical Aerospace Group from Mkt Perform to Underperform

    2/23/26 8:34:02 AM ET
    $EVTL
    Aerospace
    Industrials

    William Blair initiated coverage on Vertical Aerospace Group

    William Blair initiated coverage of Vertical Aerospace Group with a rating of Outperform

    1/7/26 8:35:04 AM ET
    $EVTL
    Aerospace
    Industrials

    $AORT
    $ATXI
    $CO
    $EVTL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    May 23, 2023 - FDA Roundup: May 23, 2023

    For Immediate Release: May 23, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA and the Veterans Health Administration announced a new collaboration to jointly develop emergency preparedness and response tools and protocols intended to help increase medical product manufacturing capacity and flexibility, and improve resilie

    5/23/23 4:06:19 PM ET
    $AORT
    Medical/Dental Instruments
    Health Care

    $AORT
    $ATXI
    $CO
    $EVTL
    Leadership Updates

    Live Leadership Updates

    View All

    Vertical Aerospace Selects Evolito as Electric Propulsion Unit Partner for Valo

    Evolito to supply electric propulsion units for Valo, Vertical's commercial aircraft Companies to jointly certify the electric engines with UK CAA and EASA Evolito joins Honeywell, Syensqo and Aciturri as key suppliers, strengthening Valo's path to commercialization Vertical Aerospace ("Vertical" or "Company") (NYSE:EVTL), a global aerospace and technology company that is pioneering electric aviation, today announced a new long-term partnership with Evolito, a leader in high-performance electric propulsion systems, to supply electric propulsion units ("EPUs") - electric engines - that will power Valo, Vertical's commercial eVTOL aircraft. This press release features multimedia. V

    2/5/26 4:00:00 AM ET
    $EVTL
    Aerospace
    Industrials

    SpinLaunch Appoints Aerospace Pioneer Dómhnal Slattery and Defense & Satcom Veteran Peter Hadinger to Advisory Board

    Appointments strengthen SpinLaunch's leadership in defense and sovereign partnerships as the Meridian constellation transitions from development to operational deployment. SpinLaunch, a pioneer of disruptive space solutions, today announced the appointment of aerospace pioneer and investor Dómhnal Slattery and Peter Hadinger, who previously served as Chief Technology Officer and as President, US Government at Inmarsat, to the SpinLaunch Advisory Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251119694872/en/SpinLaunch announces the appointment of Dómhnal Slattery to its Advisory Board. The appointments mark an important

    11/19/25 12:00:00 PM ET
    $EVTL
    Aerospace
    Industrials

    Cassava Reports Q3 2025 Financials Results and Provides Business Update

    Simufilam advancing towards a clinical study expected to begin in H1 2026 for the potential treatment of TSC-related epilepsyFurther fortified our strategic capabilities with the appointment of Dawn C. Bir to the Board of Directors$106.1 million in cash and cash equivalents at September 30, 2025. Expected to support operations into 2027 AUSTIN, Texas, Nov. 12, 2025 (GLOBE NEWSWIRE) -- – Cassava Sciences, Inc. (NASDAQ:SAVA, "Cassava", the "Company")), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as Tuberous Sclerosis Complex (TSC)-related epilepsy, today reported financial results for the third quarter ende

    11/12/25 8:00:00 AM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AORT
    $ATXI
    $CO
    $EVTL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Vertical Aerospace Ltd.

    SC 13D/A - Vertical Aerospace Ltd. (0001867102) (Subject)

    11/25/24 5:13:22 PM ET
    $EVTL
    Aerospace
    Industrials

    Amendment: SEC Form SC 13D/A filed by Vertical Aerospace Ltd.

    SC 13D/A - Vertical Aerospace Ltd. (0001867102) (Subject)

    11/25/24 7:46:39 AM ET
    $EVTL
    Aerospace
    Industrials

    Amendment: SEC Form SC 13D/A filed by Avenue Therapeutics Inc.

    SC 13D/A - AVENUE THERAPEUTICS, INC. (0001644963) (Subject)

    11/15/24 4:05:50 PM ET
    $ATXI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AORT
    $ATXI
    $CO
    $EVTL
    Financials

    Live finance-specific insights

    View All

    Vertical Aerospace Assembles Comprehensive Financing Package of up to $850 million

    The company today raised $50 million of common equity and expects to receive a further $30 million over the coming weeks, representing approximately $160 million of available capital to execute key certification milestones over the remainder of 2026. In addition to the equity raise, the new comprehensive financing package agreement in principle provides for access to up to $800 million in additional committed capital, across a range of facilities through 2027 and beyond. Existing convertible notes held by Mudrick Capital to be amended to extend maturity from December 2028 to December 2030, ensuring debt matures after planned 2028 certification and first Valo deliveries to customers;

    3/30/26 9:15:00 AM ET
    $EVTL
    Aerospace
    Industrials

    Talkspace Announces Fourth Quarter and Full Year 2025 Results

    4Q 2025 total revenue grew 29% year-over-year to $63.0 million4Q 2025 net income of $4.8 million and adjusted EBITDA1 of $6.6 million Full-year 2025 total revenue grew 22% year-over-year to $228.9 millionFull-year 2025 net income of $7.8 millionFull-year 2025 adjusted EBITDA1 grew 127% year-over-year to $15.8 million  NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported fourth quarter and full year 2025 financial results.   Three Months EndedDecember 31, Year EndedDecember 31,   2025 2024 2025 2024   Results % Variancefrom PriorYear Results % Variancefrom PriorYear (In thousands unless otherwise noted)Unaudited Unaudited  

    2/19/26 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Artivion Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter Highlights: GAAP revenue was $116.0 million in the fourth quarter of 2025 versus $97.3 million in the fourth quarter of 2024. For the full year, GAAP revenue was $441.3 million versus $388.5 million for the full year of 2024. GAAP net income was $2.4 million, or $0.05 per fully diluted share, in the fourth quarter of 2025, versus a net loss of $(16.5) million, or $(0.39) per fully diluted share in the fourth quarter of 2024. For the full year 2025, GAAP net income was $9.8 million, versus a net loss of $(13.4) million for the full year 2024.Adjusted revenue1 was $118.3 million in the fourth quarter of 2025, an increase of 18% on an adjusted constant currency basis compared to

    2/12/26 4:05:00 PM ET
    $AORT
    Medical/Dental Instruments
    Health Care